1. Create Account | Help
CURRENT ORDER
0 Items - Edit
Total: $000.00

History

Discover how we became a leader in the dental bone grafting industry by following major milestones and events in our company timeline.

Timeline

  • 1996 - Osteogenics Biomedical Inc 1996 - Osteogenics Biomedical enters the dental bone grafting market with a dense PTFE membrane. The company is incorporated with a mission of developing dental bone grafting products to increase the predictability of regenerative procedures.
  • 3rd generation PTFE membrane Regentex textured surface 1998 - Osteogenics introduces a new patented surface technology - the Regentex™ textured surface - to the dense PTFE membrane. This 3rd generation PTFE membrane combines the benefits of a membrane occlusive to bacteria with a textured surface that helps stabilize the membrane and soft tissue flap.
  • Dental Bone Graft Guided Bone Regeneration 1999 - Osteogenics introduces the first nitride-coated ridge augmentation mesh - Osteo-Mesh™ TM-300.
  • Permaridge synthetic ridge augmentation matrix CeraMed Dental 1999 - Osteogenics acquires Permaridge® synthetic ridge augmentation matrix from CeraMed Dental. Permaridge® helps correct alveolar ridge resorption, providing denture wearers with more stable and comfortable dentures.
  • Osteogenics Biomedical - Dental Bone Grafting Experts 1999 - Osteogenics relocates to a larger manufacturing facility in Lubbock, TX.
  • PTFE Membrane Guided Bone Regeneration 2000 - Osteogenics receives a technique patent for treating alveolar bone defects using dense PTFE membranes - the Cytoplast Technique™. The Cytoplast Technique™ for socket grafting is the first technique utilizing membranes left exposed, thereby reducing surgical time, preserving soft tissue architecture and increasing keratinzed mucosa. Because the Cytoplast™ dense PTFE membranes are impervious to bacteria, they are especially well-suited to be left exposed in the oral environment.
  • Monofilament PTFE Suture Resorbable Collagen Membrane 2002 - Osteogenics expands its regenerative portfolio with the addition of Cytoplast™ PTFE Suture and Cytoplast™ RTM collagen membranes. The company is one of only two companies in the world to manufacture PTFE suture.
  • ISO 9001 ISO 13485 quality certifications 2003 - Osteogenics receives ISO 9001 and ISO 13485 quality certifications, demonstrating compliance with strict European quality guidelines.
  • Corporate Headquarters and Manufacturing 2005 - Osteogenics moves its corporate headquarters and manufacturing operations into a new 7,000 square-foot state-of-the-art facility in Lubbock, TX.
  • MDD/93/42/EEC certification 2007 - The company receives MDD/93/42/EEC certification, allowing the company to expand into Europe by distributing under the CE mark.
  • PTFE Barrier Membrane 2007 - The company applies its Regentex™ surfaced technology to its line of titanium-reinforced membranes. Osteogenics also introduces four new titanium-reinforced application-specific membrane sizes.
  • Osteogenics Clinical Education 2008 - Osteogenics Clinical Education™, a division of Osteogenics Biomedical, is established with a mission of providing interactive, hands-on clinical education in bone grafting and implant dentistry.
  • PTFE Membrane Barrier Membrane Dental Membrane 2009 - Osteogenics introduces two application-specific titanium-reinforced membrane sizes. The new sizes are the first to incorporate pilot holes and a broader titanium frame.
  • 2009 - 170 clinicians from six countries and three continents attend Osteogenics Clinical Education's™ first global bone grafting symposium in Scottsdale, Arizona.
  • Bone Scrapers Guided Bone Regeneration 2010 - Osteogenics signs an agreement with META Advanced Medical Technology in Italy, giving the company distribution rights in the U.S. and Canada for its dental bone grafting products, including its autogenous bone collectors Micross and Safescraper®, and crestal sinus lift kit, SinCrest.
  • Barrier Membrane Fixation 2010 - Osteogenics introduces the Pro-fix™ Precision Fixation System. Pro-fix™ is first introduced with self-drilling membrane fixation screws and will soon include self-drilling tenting screws and self-tapping bone fixation screws.
  • Dental Bone Grafting Guided Bone Regeneration 2010 - Osteogenics introduces enCore® Combination Allograft and enCore® Mineralized Allograft, the first dental bone grafting product introduced by Osteogenics. The combination allograft is the first particulate dental bone grafting product to combine mineralized and demineralized bone in a single bottle.
  • Manufacturing Facility 2012 - Osteogenics moves into a new 10,000 square-foot manufacturing facility, adding to its corporate headquarters campus in Lubbock, Texas.
  • Manufacturing Facility 2014 - Osteogenics undergoes major renovations to its corporate headquarters to maximize space for company growth.
  • NovaBone® Dental Putty 2015 - Osteogenics acquires exclusive distribution rights to sell the synthetic, osteostimulative NovaBone® Dental products in the U.S. and Canada. Within the NovaBone® product line is an especially unique product, NovaBone® Dental Putty, a pre-mixed moldable putty that is available in a variety of delivery systems.
  • Zcore™ 2015 - Osteogenics introduces Zcore™ porcine xenograft particulate, an osteoconductive anorganic bone mineral derived from porcine cancellous bone. Hyper-porosity of the porcine cancellous matrix and intra-particle space reduces bulk density of the graft, allowing 88 – 95% empty space for bone growth.
  • Resorba™2016 - Osteogenics acquires the exclusive North American distribution rights for the premium German dental suture brand, Resorba®. Resorba® sutures are made from unique materials that are designed especially for dentistry and are available with black 300-series stainless steel needles that enhance visualization in the mouth.
  • EnCore™2016 - Osteogenics introduces the newest product to complement the family of enCore® allografts - enCore® OD allograft, comprised of 30% mineralized cortical bone and 70% mineralized cancellous bone. enCore® OD is designed to be used with osseodensification (OD) protocols.
  • Zcore™2016 - Osteogenics expands its regenerative portfolio with the addition of absorbable collagen wound dressings - Cytoplast™ RTMPlug, RTMFoam, and RTMTape.
Copyright © 2009-16 Osteogenics Biomedical, All Rights Reserved.
Legal Statements | Customer Service Policies